Skip to main content

Table 4 Changes in continuous glucose monitoring data and dietary patterns in intervention group after controlling for patients’ baseline characteristics and missing data

From: The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes

 

IP-weighted Coefficient

IP-weighted

95% Confidence Intervals

Mean glucose levels, mg/dl

−10.44

−21.83, 0.96

Glycemic variability measured through standard deviation

−3.94*

−7.59, − 0.29

Percentage of time in range (70–180 mg/dl)

7.25*

1.65, 12.85

Percentage of time above range (> 180 mg /dl)

− 6.10*

− 12.08, − 0.13

Percentage of time above range (> 250 mg /dl)

−3.05

− 8.03, 1.93

Percentage of time below range (< 70 mg/dl)

− 0.63

−1.39, 0.12

Percentage of time below range (< 54 mg/dl)

− 0.93

− 1.97, 0.09

Percentage of the area over the blood concentration-time curve

−8.01

− 17.5, 1.50

Percentage of the area under the blood concentration-time curve

− 0.15

− 0.32, 0.01

Dietary patterns

 Daily caloric intake, Kcal/day

  Total

− 197.66***

− 282.87, − 112.467

  From carbohydrates

− 95.68***

−141.95, − 49.42

  From proteins

−33.61***

−50.68, − 16.54

  From fat

−62.75*

− 112.83, − 12.67

  1. Each model was controlled for covariates (sex, age, educational level, nutritional status body mass index, time since diagnosis and type of pharmacological treatment) and the baseline treatment modification
  2. *p < 0.05; **p < 0.01; ***p < 0.001